CHAPTER 1. INTRODUCTION
1.1. Market Definition
1.2. Executive Summary
1.3. The Scope of the Study
CHAPTER 2. RESEARCH METHODOLOGY
2.1. Secondary Research
2.2. Primary Research
2.3. Analytic Tools and Model
2.4. Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5. Expert Validation
2.6. Study Timeline
CHAPTER 3. MARKET ANALYSIS
3.1. Industry Value Chain Analysis
3.2. Porter's Five Force Analysis
3.2.1. Bargaining Power of Buyers
3.2.2. Bargaining Power of Suppliers
3.2.3. Threats of Substitutes
3.2.4. Threats of New Entrants
3.2.5. Degree of Competition
3.3. PESTLE Analysis
3.3.1. Political
3.3.2. Economical
3.3.3. Social
3.3.4. Technological
3.3.5. Legal
3.3.6. Environmental
3.4. SWOT Analysis
3.4.1. Strengths
3.4.2. Weakness
3.4.3. Opportunities
3.4.4. Threats
3.5. Y-O-Y Analysis
CHAPTER 4. MARKET DYNAMICS
4.1. Market Drivers
4.1.1. High prevalence and large economic burden of chronic diseases
4.1.2. Rapid growth in pharmaceutical and biotechnology industries
4.1.3. Increasing number of new drug launches
4.1.4. Strong R&D investments in the life sciences industry
4.1.5. Increasing government support for pharmaceutical and biotechnology industries
4.2. Market Restraints & Challenges
4.2.1. Strict regulatory norms
4.2.2. Rising pressure regarding adoption of animal-free testing methods
4.3. Market Opportunities
4.3.1. The launch of biological products
4.3.2. Increasing outsourcing activities in the pharmaceutical industry
CHAPTER 5. GLOBAL PYROGEN TESTING MARKET – BY PRODUCT
5.1. Kits and Reagents
5.2. Services
5.3. Instruments
CHAPTER 6. GLOBAL PYROGEN TESTING MARKET – BY APPLICATION
6.1. Pharmaceutical and Biological Manufacturing
6.2. Medical Device Manufacturing
6.3. Other Applications
CHAPTER 7. GLOBAL PYROGEN TESTING MARKET – BY TEST TYPE
7.1. LAL (Limulus Amoebocyte Lysate) Tests
7.1.1. Chromogenic Tests
7.1.2. Turbid metric Tests
7.1.3. Gel Clot Tests
7.3. In Vitro Tests
7.4. Rabbit Tests
CHAPTER 8. GLOBAL PYROGEN TESTING MARKET - BY GEOGRAPHY
8.1. Introduction
8.2. North America
8.2.1. U.S.
8.2.2. Canada
8.2.3. Mexico
8.2.4. Costa Rica
8.3. South America
8.3.1. Brazil
8.3.2. Argentina
8.3.3. Chile
8.3.4. Columbia
8.3.5. Others
8.4. Europe
8.4.1. U.K.
8.4.2. Germany
8.4.3. France
8.4.4. Italy
8.4.5. Spain
8.4.6. Russia
8.4.7. Netherlands
8.4.8. Switzerland
8.4.9. Poland
8.4.10. Others
8.5. APAC
8.5.1. China
8.5.2. Japan
8.5.3. India
8.5.4. South Korea
8.5.5. Australia & New Zealand
8.5.6. Malaysia
8.5.7. Singapore
8.5.8. Others
8.6. Middle East & Africa
8.6.1. UAE
8.6.2. Saudi Arabia
8.6.3. Iran
8.6.4. Iraq
8.6.5. Qatar
8.6.6. South Africa
8.6.7. Algeria
8.6.8. Morocco
8.6.9. Nigeria
8.6.10. Egypt
8.6.11. Others
CHAPTER 9. GLOBAL PYROGEN TESTING MARKET - COMPANY PROFILES
9.1. Wako Chemicals Usa, Inc
9.2. Charles River Laboratories, Inc.
9.3. Lonza Group
9.4. Merck KGaA
9.5. Ellab A/S
9.6. Genscript
9.7. Hyglos GmbH
9.8. Thermo Fisher Scientific, Inc.
9.9. Associates of Cape Cod, Inc.
9.10. WUXI Pharmatech (Cayman) Inc.
9.11. Hyglos GmbH
9.12. Microcoat Biotechnologie GmbH
9.13. Ellab A/S
9.14. Pyrostar
CHAPTER 10. GLOBAL PYROGEN TESTING MARKET - COMPETITIVE
LANDSCAPE
10.1. Market Share Analysis
10.2. Strategies adopted by top companies
10.3. Mergers, Acquisitions, Collaborations & Agreements
CHAPTER 11. MARKET INSIGHTS
11.1. Industry Experts Insights
11.2. Analysts Opinions
11.3. Investment Opportunities
CHAPTER 12. APPENDIX
12.1. List of Tables
12.2. List of Figures
